Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.

Global blood industry to reach $28.8 billion by 2017

The markets for blood products, blood tests and blood processing equipment are evolving with the help of new products, technologies, and equipment.

  • Inicia sesión para ver los comentarios

  • Sé el primero en recomendar esto

Global blood industry to reach $28.8 billion by 2017

  1. 1. Global Blood Industry To Reach $28.8 Billion By 2017 The markets for blood products, blood tests and blood processing equipment are evolving with the help of new products, technologies, and equipment. The key driving forces impacting the blood industry include the cost of collection and processing, technological advances, an aging population, demand for plasma-derived therapeutics, andchanges in the incidence of diseases and surgical procedures and catastrophes requiring blood transfusions. Since BCC Research first looked at this market in 2001, there have been mergers, consolidations, and acquisitions among the major companies as well as advances in technology that have allowed for obtaining more red blood cells from fewer donors. Taking due note of the market dynamics, BCC Research has published a report covering the wide range of products and services that comprise the global blood industry marketplace. According to the report, The Global Blood Industry (Report code: HLC008H), the global market for blood products reached $23.5 billion in 2012. The market is expected to reach $28.8 billion in 2017, registering a compound annual growth rate (CAGR) of 4.1%. This study encompasses the wide range of products and services that comprise the global blood industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other select regions. The report places special emphasison blood for donation and the components and derived products from such blood and plasma.The study is also focused on the products used to provide and support collection, processing, and transfusion of blood. The study covers the major aspects of blood and plasma collection/transfusion including autologous donations, apheresis, fractionation, blood salvage, and stem cells. The major plasma products such as coagulation factors, human serum albumin, and immunoglobulins are also analyzed. The scope and character of the blood-testing segment is constantly changing, and hence the impact of new products, technologies and equipment are analyzed too. The study also covers federal regulationsfor blood supply, blood system management, and industry players.The report also touches upon the international developments in blood banking and related areas, as well as research and patents that will affect the future of the blood industry. A safe and adequate blood supply is essential to the practice of modern medicine. New advances, particularly in the area of automation, have enhanced the safety and availability of blood. With its broad scope and in-depth analyses, this study will prove to be a valuable resource to anyone involved with or interested in the blood industry. Thisreport will prove valuable to a variety of readers, including industry executives, managers and planners, researchers, industry analysts, and investors.

×